2-(dimethylamino)ethyl methacrylate has been researched along with indocyanine green in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ding, Y; Ji, T; Li, Y; Nie, G; Su, S; Tian, Y; Wu, M; Wu, Y | 1 |
1 other study(ies) available for 2-(dimethylamino)ethyl methacrylate and indocyanine green
Article | Year |
---|---|
"Triple-punch" strategy for triple negative breast cancer therapy with minimized drug dosage and improved antitumor efficacy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Carriers; Endocytosis; Female; Humans; Indocyanine Green; Inhibitor of Apoptosis Proteins; Intracellular Space; Lactic Acid; Methacrylates; Mice; Mice, Inbred BALB C; Nanomedicine; Nanoparticles; Paclitaxel; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; RNA, Small Interfering; Survivin; Triple Negative Breast Neoplasms | 2015 |